Supreme Court to Decide Immunity and Billions in Purdue Pharma Bankruptcy Case

The Supreme Court is set to hear arguments on whether a settlement agreement that grants immunity to the Sackler family, former owners of Purdue Pharma, from civil lawsuits related to the opioid crisis violates federal law. The case could have far-reaching implications for organizations seeking bankruptcy protection to resolve mass injury claims. The legal maneuver in question, known as third-party nonconsensual releases, has been used in settlements involving other entities facing mass injury claims, such as the Boy Scouts of America and the Catholic Church. The outcome of the case could determine the extent of legal protections granted in such settlements and potentially upend similar agreements.
- At Core of Purdue Pharma Case: Who Can Get Immunity in Settlements? The New York Times
- Purdue Pharma bankruptcy plan that shields Sackler family faces Supreme Court review CBS News
- Fate of Billions for Opioid Victims From Sacklers Rests With Supreme Court The New York Times
- Opioid maker Purdue’s bankruptcy case comes before Supreme Court SCOTUSblog
- View Full Coverage on Google News
Reading Insights
0
9
5 min
vs 6 min read
90%
1,019 → 106 words
Want the full story? Read the original article
Read on The New York Times